India inks deal to make 200 million doses of Sputnik V Covid vaccine

Moscow - Russian firm to partner with Virchow Group for vaccine production.


Published: Mon 22 Mar 2021, 12:29 PM

The maker of Russia's Sputnik V coronavirus vaccine said Monday it had signed an agreement with an India-based pharmaceuticals giant for the production of up to 200 million doses of the jab a year.

The Russian Direct Investment Fund (RDIF), which has backed the development of Sputnik, said in a statement it partnered with the Virchow Group to produce up to 200 million doses of Sputnik a year in India.


More news from coronavirus